1. Home
  2. EXAS vs AA Comparison

EXAS vs AA Comparison

Compare EXAS & AA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • AA
  • Stock Information
  • Founded
  • EXAS 1995
  • AA 1888
  • Country
  • EXAS United States
  • AA United States
  • Employees
  • EXAS N/A
  • AA N/A
  • Industry
  • EXAS Medical Specialities
  • AA Aluminum
  • Sector
  • EXAS Health Care
  • AA Industrials
  • Exchange
  • EXAS Nasdaq
  • AA Nasdaq
  • Market Cap
  • EXAS 12.3B
  • AA 10.5B
  • IPO Year
  • EXAS N/A
  • AA 2016
  • Fundamental
  • Price
  • EXAS $49.33
  • AA $44.02
  • Analyst Decision
  • EXAS Strong Buy
  • AA Buy
  • Analyst Count
  • EXAS 17
  • AA 11
  • Target Price
  • EXAS $73.07
  • AA $44.60
  • AVG Volume (30 Days)
  • EXAS 3.3M
  • AA 4.7M
  • Earning Date
  • EXAS 11-05-2024
  • AA 10-16-2024
  • Dividend Yield
  • EXAS N/A
  • AA 0.91%
  • EPS Growth
  • EXAS N/A
  • AA N/A
  • EPS
  • EXAS N/A
  • AA N/A
  • Revenue
  • EXAS $2,692,328,000.00
  • AA $11,004,000,000.00
  • Revenue This Year
  • EXAS $12.41
  • AA $13.75
  • Revenue Next Year
  • EXAS $11.64
  • AA $3.47
  • P/E Ratio
  • EXAS N/A
  • AA N/A
  • Revenue Growth
  • EXAS 11.91
  • AA 3.63
  • 52 Week Low
  • EXAS $40.62
  • AA $23.80
  • 52 Week High
  • EXAS $79.62
  • AA $46.55
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 22.62
  • AA 59.60
  • Support Level
  • EXAS $48.02
  • AA $40.11
  • Resistance Level
  • EXAS $52.32
  • AA $46.55
  • Average True Range (ATR)
  • EXAS 2.86
  • AA 1.49
  • MACD
  • EXAS -1.89
  • AA -0.21
  • Stochastic Oscillator
  • EXAS 5.28
  • AA 64.40

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.

About AA Alcoa Corporation

Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.

Share on Social Networks: